Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Longeveron Inc (LGVN)

Longeveron Inc (LGVN)
1.4600 x 1 1.6900 x 1
Post-market by (Cboe BZX)
1.5600 +0.0400 (+2.63%) 04/22/25 [NASDAQ]
1.4600 x 1 1.6900 x 1
Post-market 1.6100 +0.0500 (+3.21%) 16:59 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.4500
Day High
1.5600
Open 1.5500
Previous Close 1.5200 1.5200
Volume 109,600 109,600
Avg Vol 117,805 117,805
Stochastic %K 76.69% 76.69%
Weighted Alpha -71.52 -71.52
5-Day Change +0.1150 (+7.96%) +0.1150 (+7.96%)
52-Week Range 0.7707 - 6.4000 0.7707 - 6.4000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,691
  • Shares Outstanding, K 14,928
  • Annual Sales, $ 2,390 K
  • Annual Income, $ -15,970 K
  • EBIT $ -17 M
  • EBITDA $ -16 M
  • 60-Month Beta 0.39
  • Price/Sales 9.11
  • Price/Cash Flow N/A
  • Price/Book 0.99

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.34
  • Number of Estimates 2
  • High Estimate -0.30
  • Low Estimate -0.37
  • Prior Year -1.61
  • Growth Rate Est. (year over year) +78.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2000 +30.00%
on 04/09/25
Period Open: 1.8500
1.9198 -18.74%
on 03/24/25
-0.2900 (-15.68%)
since 03/21/25
3-Month
1.2000 +30.00%
on 04/09/25
Period Open: 1.7200
1.9198 -18.74%
on 03/24/25
-0.1600 (-9.30%)
since 01/22/25
52-Week
0.7707 +102.41%
on 06/11/24
Period Open: 1.8700
6.4000 -75.63%
on 07/10/24
-0.3100 (-16.58%)
since 04/22/24

Most Recent Stories

More News
Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025

LGVN : 1.5600 (+2.63%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease

LGVN : 1.5600 (+2.63%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease

LGVN : 1.5600 (+2.63%)
LGVNR : 0.0005 (-37.50%)
Longeveron® to Present at the 37th Annual Roth Conference

LGVN : 1.5600 (+2.63%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update

LGVN : 1.5600 (+2.63%)
LGVNR : 0.0005 (-37.50%)
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025

LGVN : 1.5600 (+2.63%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™

LGVN : 1.5600 (+2.63%)
LGVNR : 0.0005 (-37.50%)
Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025

LGVN : 1.5600 (+2.63%)
LGVNR : 0.0005 (-37.50%)
Longeveron Inc. CEO Wa’el Hashad to Present at Biotech Showcase 2025 on January 14

Longeveron Inc. CEO Wa’el Hashad will present at Biotech Showcase on January 14, 2025, discussing regenerative medicine developments.Quiver AI SummaryLongeveron Inc., a clinical stage biotechnology company...

LGVN : 1.5600 (+2.63%)
Longeveron to Present at Biotech Showcase 2025

LGVN : 1.5600 (+2.63%)
LGVNR : 0.0005 (-37.50%)

Business Summary

Longeveron Inc. is a clinical stage biotechnology company. It engages in developing cellular therapies for chronic aging-related and life-threatening conditions. The company's investigational product includes LOMECEL-B(TM). Longeveron Inc. is based in MIAMI.

See More

Key Turning Points

3rd Resistance Point 1.7067
2nd Resistance Point 1.6333
1st Resistance Point 1.5967
Last Price 1.5600
1st Support Level 1.4867
2nd Support Level 1.4133
3rd Support Level 1.3767

See More

52-Week High 6.4000
Fibonacci 61.8% 4.2496
Fibonacci 50% 3.5854
Fibonacci 38.2% 2.9211
Last Price 1.5600
52-Week Low 0.7707

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro